证券代码:002455 证券简称:百川股份 公告编号:2025-062 债券代码:127075 债券简称:百川转 2 江苏百川高科新材料股份有限公司 关于公司合并报表范围内提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 特别风险提示： 截至本公告日，公司除合并报表范围内母子孙公司之间互保外，未进行其他对外担保。无 逾期担保情况，无涉及诉讼的担保，未因担保被判决败诉而承担损失。 公司母子孙公司之间担保余额超过最近一期经审计净资产100%、有对资产负债率超过70% 的被担保对象进行担保，敬请投资者注意担保风险。 一、担保情况概述 （一）担保审议情况 江苏百川高科新材料股份有限公司（以下简称"公司"）于 2024 年 9 月 25 日召开的第六 届董事会第二十九次会议和 2024 年 10 月 14 日召开的 2024 年第二次临时股东大会审议通过了 《关于为子公司新增担保额度预计的议案》，为进一步满足合并报表范围内母子孙公司日常生 产经营和业务发展资金需要，母子孙公司之间拟向相关金融机构申请的融资提供新增担保额度， 本次新增担保额度后，担保总额 ...

Core Viewpoint - The company is facing challenges in its new energy segment due to declining battery prices and low capacity utilization, which have negatively impacted its gross margin [2]. Company Summary - The subsidiary, Haiji New Energy, specializes in the research, production, sales, and service of lithium-ion batteries and battery packs [2]. - The negative gross margin in the new energy segment is attributed to a decline in battery product prices, low capacity utilization, and ineffective allocation of fixed costs [2]. - The company is actively expanding its sales channels and seeking to connect with overseas customers to achieve export growth and improve capacity utilization [2].

Group 1 - Jiangsu Baichuan High-tech Materials Co., Ltd. received notification from its controlling shareholder, Mr. Zheng Tiejiang, regarding the release and pledge of part of his shares [1] - Mr. Zheng released 620.27 million shares, accounting for 7.36% of his holdings and 1.04% of the company's total share capital [1] - The release date for the shares was September 2, 2025, and the shares were originally pledged on January 3, 2024 [1] Group 2 - The company reported that the pledged shares do not involve any major asset restructuring or performance compensation obligations [1] - As of the announcement date, the total pledged shares by Mr. Zheng and his associates amounted to 9,233 million shares, representing 15.54% of the total shares [2] - The company stated that Mr. Zheng's credit status is good, and there is no risk of forced liquidation of the pledged shares, indicating that the pledge risk is under control [2]

Group 1 - The core point of the article is that Baichuan Co., Ltd. announced the release and re-pledging of shares by its controlling shareholder Zheng Tiejiang, indicating ongoing financing activities [2] - Zheng Tiejiang released 6.2027 million shares, which accounts for 7.36% of his holdings and 1.04% of the company's total share capital [2] - Simultaneously, Zheng Tiejiang re-pledged the same amount of shares (6.2027 million), with the purpose of the pledge being for financing needs [2]

证券代码：002455 证券简称：百川股份 公告编号：2025-061 债券代码：127075 债券简称：百川转 2 江苏百川高科新材料股份有限公司 关于控股股东部分股份解除质押和质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 近日，江苏百川高科新材料股份有限公司(以下简称"公司")接到控股股东郑铁江先生 通知，获悉其所持有本公司的部分股份办理了解除质押和质押业务，具体事项如下： 一、股东股份解除质押和质押的基本情况 | 股东名称 | 是否为控股股东 | 本次解除质 | 占其所 | 占公司 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | 或第一大股东及 | 押股份数量 | 持股份 | 总股本 | 起始日 | 解除日期 | 质权人 | | | 其一致行动人 | （万股） | 比例 | 比例 | | | | | 郑铁江 | 是 | 620.27 | 7.36% | 1.04% | 2024.1.3 | 2025.9.2 | 广发证券股 份有限公司 | | 合计 | | 620. ...

Group 1 - The core viewpoint of the news is that Baichuan Co., Ltd. has experienced fluctuations in its stock performance and financing activities, indicating a low financing balance and a relatively high short-selling position [1][2]. - As of August 29, Baichuan's stock price decreased by 0.58%, with a trading volume of 138 million yuan. The net financing buy was -5.11 million yuan, with a total financing and securities balance of 145 million yuan [1]. - The financing balance of Baichuan accounts for 3.58% of its circulating market value, which is below the 30% percentile level over the past year, indicating a low level of financing [1]. Group 2 - As of June 30, Baichuan reported a total of 80,600 shareholders, a decrease of 6.93% from the previous period, while the average circulating shares per person increased by 7.44% to 6,438 shares [2]. - For the first half of 2025, Baichuan achieved an operating income of 2.91 billion yuan, representing a year-on-year growth of 10.40%. However, the net profit attributable to shareholders decreased by 47.06% to 53.93 million yuan [2]. - Since its A-share listing, Baichuan has distributed a total of 550 million yuan in dividends, with 65.31 million yuan distributed over the past three years [3].

Group 1 - The core viewpoint of the article highlights that the company's profit decline in the first half of the year is primarily due to losses in the new energy sector [2] - The company has commenced production of anode and cathode materials, which will enable group supply and aims to leverage integrated advantages to further reduce material procurement costs [2] - The company is actively expanding sales channels and engaging with overseas customers to strive for export growth and improve capacity utilization, thereby enhancing the performance of the new energy sector [2]

Group 1 - The company Baichuan Co., Ltd. announced on August 28 that the total balance of guarantees provided within the consolidated scope of the company is approximately 5.403 billion yuan, which accounts for 272.74% of the company's most recent audited net assets [1] - The announcement highlights the significant level of inter-company guarantees among the parent, subsidiary, and grandchild companies [1] Group 2 - The news also mentions a breakthrough in medical science with the world's first successful transplantation of gene-edited pig lungs into a human, raising questions about the timeline for clinical applications [1] - The dialogue with key participants in this medical advancement indicates ongoing research and potential future developments in the field of gene editing and organ transplantation [1]

Core Insights - Baichuan Co., Ltd. (002455.SZ) reported its 2025 semi-annual results, achieving a revenue of 2.91 billion yuan and a net profit attributable to shareholders of 53.92 million yuan, with operating cash flow reaching 360 million yuan, marking a historical high for both revenue and operating cash flow [1] Financial Performance - The company achieved a record revenue of 2.91 billion yuan in the first half of 2025 [1] - The net profit attributable to shareholders was 53.92 million yuan [1] - Operating cash flow net amount reached 360 million yuan, also a historical high [1]

Core Viewpoint - Baichuan Co., Ltd. reported a historical high in revenue for the first half of 2025, driven by strong performance in its new materials segment, particularly in lithium battery anode materials and ultra-high power graphite electrodes [1][2]. Financial Performance - The company achieved a revenue of 2.91 billion yuan, a year-on-year increase of 10.40%, with domestic business revenue reaching 2.30 billion yuan, up 16.67% [1]. - The net profit attributable to shareholders was 53.93 million yuan, with a non-recurring net profit of 47.89 million yuan; net cash flow from operating activities was 360 million yuan, reflecting an 18.86% increase [1]. Business Segments - Chemical and new energy businesses maintained stable revenue, generating 2.20 billion yuan and 170 million yuan, respectively [1]. - The new materials segment was the largest growth driver, with revenue of 542 million yuan, a significant year-on-year increase of 106.72%, and a gross margin improvement of 11.78 percentage points [1]. Industry Positioning - The company is one of the few in China capable of integrating the "needle coke—graphitization—anode materials" production chain, which enhances cost efficiency and risk resilience compared to peers [2]. - The completion of the "annual production of 30,000 tons of graphite anode materials" project in April 2025 has stabilized production and increased output, positioning the company to capitalize on market demand [2]. Technological Innovation - The company has invested heavily in R&D, with expenses reaching 61.75 million yuan in the first half of 2025, achieving significant breakthroughs in new materials and lithium battery core technologies [3]. - Notable advancements include the successful development of key materials such as lithium manganese iron phosphate and lithium replenishment agents, with the fourth-generation production line achieving new performance benchmarks [3].